{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:13:48Z","timestamp":1762236828781,"version":"build-2065373602"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>In the post-COVID-19 era, understanding the long-term impact of Long COVID on the immune system is essential for deciphering its influence on lung cancer pathogenesis and immunotherapeutic efficacy. This review comprehensively examines how persistent COVID-19 sequelae-manifested as chronic inflammation, pulmonary fibrosis, cytokine dysregulation, and T-cell exhaustion can reshape the lung cancer microenvironment. In addition, the emerging roles of memory B cells and altered neutrophil function in promoting tumorigenesis are discussed. Importantly, we analyze recent clinical evidence suggesting that COVID-19 vaccination may enhance the efficacy of immune checkpoint inhibitors, potentially by modulating host immunity. By integrating mechanistic insights with clinical observations, this review aims to illuminate the challenges and opportunities at the intersection of Long COVID and lung cancer treatment, thereby fostering the development of personalized therapeutic strategies in the post-pandemic era.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1657691","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:21Z","timestamp":1762236621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting lung cancer immunotherapy in the era of long COVID: mechanistic insights and therapeutic implications"],"prefix":"10.3389","volume":"15","author":[{"given":"Xingyao","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1349.e1341","DOI":"10.1016\/j.cmi.2021.05.008","article-title":"SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects","volume":"27","author":"Achiron","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ijc.29945","article-title":"Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human","volume":"138","author":"Andzinski","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/0008-5472.CAN-13-2322","article-title":"Inflammation amplifier, a new paradigm in cancer biology","volume":"74","author":"Atsumi","year":"2014","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/diagnostics14060621","article-title":"Short- and long-term chest-CT findings after recovery from COVID-19: A systematic review and meta-analysis","volume":"14","author":"Babar","year":"2024","journal-title":"Diagnostics (Basel)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-coV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/ijms20030593","article-title":"Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets","volume":"20","author":"Ballester","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/MPA.0b013e31823cdd10","article-title":"IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines","volume":"41","author":"Block","year":"2012","journal-title":"Pancreas"},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: A systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-coV-2: A multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/ijri.IJRI_469_16","article-title":"Follow-up chest radiographic findings in patients with MERS-CoV after recovery","volume":"27","author":"Das","year":"2017","journal-title":"Indian J. Radiol. Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6890-3-3","article-title":"Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods","volume":"3","author":"Doeing","year":"2003","journal-title":"BMC Clin. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/eji.201646875","article-title":"Immune checkpoints and their inhibition in cancer and infectious diseases","volume":"47","author":"Dyck","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3892\/or_00000718","article-title":"The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer","volume":"23","author":"Feng","year":"2010","journal-title":"Oncol. Rep."},{"key":"B21","article-title":"Physiology, renin angiotensin system","volume-title":"StatPearls","author":"Fountain","year":"2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"Jc41","DOI":"10.7326\/J23-0020","article-title":"In critically ill patients with COVID-19, IL-6 receptor antagonists reduced mortality vs. control at 180 d","volume":"176","author":"Fuller","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic Malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5795","article-title":"A persistent neutrophil-associated immune signature characterizes post\u2013COVID-19 pulmonary sequelae","volume":"14","author":"George","year":"2022","journal-title":"Sci. Trans. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2301947","DOI":"10.1183\/13993003.01947-2023","article-title":"Single-cell sequencing reveals cellular landscape alterations in the airway mucosa of patients with pulmonary long COVID","volume":"64","author":"Gerayeli","year":"2024","journal-title":"Eur. Respir. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium","volume":"32","author":"Grivas","year":"2021","journal-title":"Ann. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1517\/14712598.2015.1114097","article-title":"Nivolumab for treating non-small cell lung cancer","volume":"15","author":"Guibert","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","article-title":"1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study","volume":"398","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.189.1.63","article-title":"STAT3 is required for the gp130-mediated full activation of the c-myc gene","volume":"189","author":"Kiuchi","year":"1999","journal-title":"J. Exp. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1111\/all.16210","article-title":"Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1\/inflammatory to Th2 serum cytokine levels long after first COVID-19","volume":"79","author":"Kratzer","year":"2024","journal-title":"Allergy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.jtha.2023.02.033","article-title":"NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel","volume":"21","author":"Krinsky","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.804808","article-title":"Progress and challenges toward generation and maintenance of long-lived memory T lymphocyte responses during COVID-19","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"108524","DOI":"10.1016\/j.clim.2020.108524","article-title":"Long-term infection of SARS-CoV-2 changed the body\u2019s immune status","volume":"218","author":"Lin","year":"2020","journal-title":"Clin. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1488745","article-title":"Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection","volume":"15","author":"Lokau","year":"2024","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1158\/2159-8290.CD-20-0596","article-title":"Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers","volume":"10","author":"Luo","year":"2020","journal-title":"Cancer Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41467-021-21111-9","article-title":"Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers","volume":"12","author":"Marot","year":"2021","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"104153","DOI":"10.1016\/j.ebiom.2022.104153","article-title":"Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade","volume":"82","author":"Masi\u00e1","year":"2022","journal-title":"EBioMedicine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.798276","article-title":"Case report: clinical management of a patient with metastatic non-small cell lung cancer newly receiving immune checkpoint inhibition during symptomatic COVID-19","volume":"12","author":"Mellinghoff","year":"2021","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","article-title":"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses","volume":"31","author":"Morens","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ejca.2020.11.015","article-title":"SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry","volume":"144","author":"Moritz","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10.1002\/wsbm.1370","DOI":"10.1002\/wsbm.1370","article-title":"Cancer and inflammation","volume":"9","author":"Munn","year":"2017","journal-title":"Wiley Interdiscip Rev. Syst. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/1759-7714.14632","article-title":"A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancer","volume":"13","author":"Murata","year":"2022","journal-title":"Thorac. Cancer."},{"key":"B52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/JTO.0b013e3181f387e4","article-title":"The role of inflammation in the pathogenesis of non-small cell lung cancer","volume":"5","author":"O\u2019Callaghan","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.3390\/cancers14225706","article-title":"COVID-19 and lung cancer survival: an updated systematic review and meta-analysis","volume":"14","author":"Oldani","year":"2022","journal-title":"Cancers (Basel)."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1200\/JCO.20.02212","article-title":"Nivolumab and ipilimumab as maintenance therapy in extensive-disease small-cell lung cancer: checkMate 451","volume":"39","author":"Owonikoko","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002266","article-title":"Severity of COVID-19 in patients with lung cancer: evidence and challenges","volume":"9","author":"Passaro","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41590-018-0229-5","article-title":"Unique pattern of neutrophil migration and function during tumor progression","volume":"19","author":"Patel","year":"2018","journal-title":"Nat. Immunol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28209","article-title":"Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients","volume":"95","author":"Pisareva","year":"2023","journal-title":"J. Med. Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl. J. Med."},{"key":"B61","doi-asserted-by":"crossref","first-page":"109320","DOI":"10.1016\/j.celrep.2021.109320","article-title":"Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help","volume":"35","author":"Pu\u0161nik","year":"2021","journal-title":"Cell Rep."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00629","article-title":"The essential role of type I interferons in differentiation and activation of tumor-associated neutrophils","volume":"7","author":"Pylaeva","year":"2016","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13027-023-00526-7","article-title":"COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study","volume":"18","author":"Qian","year":"2023","journal-title":"Infect. Agent Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1200\/JCO.22.00912","article-title":"Phase II randomized study of ramucirumab and pembrolizumab versus standard of care in advanced non-small-cell lung cancer previously treated with immunotherapy-lung-MAP S1800A","volume":"40","author":"Reckamp","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","article-title":"PD-1-expressing SARS-coV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19","volume":"54","author":"Rha","year":"2021","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8(+) T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41591-020-0979-0","article-title":"Determinants of COVID-19 disease severity in patients with cancer","volume":"26","author":"Robilotti","year":"2020","journal-title":"Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/jnr.24917","article-title":"A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients","volume":"99","author":"Roe","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001931","article-title":"Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition","volume":"9","author":"Rogiers","year":"2021","journal-title":"J. Immunother. Cancer."},{"key":"B70","doi-asserted-by":"publisher","first-page":"21649561211056597","DOI":"10.1177\/21649561211056597","article-title":"Addressing the long COVID crisis: integrative health and long COVID","volume":"10","author":"Roth","year":"2021","journal-title":"Glob Adv. Health Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"Seow","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-coV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1111\/cas.15434","article-title":"A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer","volume":"113","author":"Shimizu","year":"2022","journal-title":"Cancer Sci."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212745","article-title":"Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level- an observational sub-analysis fit- COVID study","volume":"14","author":"Silva","year":"2023","journal-title":"Front. Immunol."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"B78","first-page":"2200970","article-title":"Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms","volume":"61","author":"Son","year":"2023","journal-title":"Eur. Respir. J."},{"key":"B79","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"rs.3.rs-80476","DOI":"10.21203\/rs.3.rs-80476\/v1","article-title":"Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2","author":"Stamper","year":"2020","journal-title":"Res. Sq"},{"key":"B81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B82","first-page":"4789","article-title":"Angiotensin II increases cancer stem cell-like phenotype in lung cancer cells","volume":"35","author":"Tawinwung","year":"2015","journal-title":"Anticancer Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/all.14827","article-title":"Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity","volume":"76","author":"Thieme","year":"2021","journal-title":"Allergy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","article-title":"Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","article-title":"Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Cell Mol. Immunol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886431","article-title":"Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-coV-2 infection","volume":"13","author":"Wiech","year":"2022","journal-title":"Front. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"103659","DOI":"10.1016\/j.isci.2021.103659","article-title":"Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG","volume":"25","author":"Winklmeier","year":"2022","journal-title":"iScience"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41467-023-40012-7","article-title":"Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID","volume":"14","author":"Woodruff","year":"2023","journal-title":"Nat. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1378\/chest.08-0814","article-title":"Anthracofibrosis, bronchial stenosis with overlying anthracotic mucosa: possibly a new occupational lung disorder: a series of seven cases From one UK hospital","volume":"134","author":"Wynn","year":"2008","journal-title":"Chest"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00276","article-title":"The ACE2\/angiotensin-(1-7)\/mas receptor axis: pleiotropic roles in cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Front. Physiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"107569","DOI":"10.1016\/j.intimp.2021.107569","article-title":"The role of IL-6\/lymphocyte ratio in the peripheral blood of severe patients with COVID-19","volume":"97","author":"Yang","year":"2021","journal-title":"Int. Immunopharmacol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41419-023-05922-w","article-title":"SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41413-020-0084-5","article-title":"Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study","volume":"8","author":"Zhang","year":"2020","journal-title":"Bone Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s12250-021-00360-4","article-title":"Sustainability of SARS-coV-2 induced humoral immune responses in COVID-19 patients from hospitalization to convalescence over six months","volume":"36","author":"Zheng","year":"2021","journal-title":"Virol. Sin."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/13543784.2020.1840549","article-title":"Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease","volume":"29","author":"Zhou","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1657691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:23Z","timestamp":1762236623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1657691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":100,"alternative-id":["10.3389\/fcimb.2025.1657691"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1657691","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1657691"}}